Varicella virus and the herpes zoster vaccine: A review of zostavax and the new AFIP recommendations

Journal of Drugs in Dermatology

Volumn 7, Issue 12, 2008, Pages 1173-1176

  Ebede, Tobechi L ^a   Zippin, Jonathan H ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARICELLA ZOSTER VACCINE;

FOOD AND DRUG ADMINISTRATION; HERPES ZOSTER; HUMAN; IMMUNOLOGY; NOTE; PRACTICE GUIDELINE; UNITED STATES; VACCINATION;

HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VACCINATION;

EID: 60549098503     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Mori I, Nishiyama Y. Herpes simplex virus and varicella-zoster virus: why do these human alphaherpesviruses behave so differently from one another? Rev Med Virol. 2005;15(6):393-406. (Pubitemid 41598004)
2. Davison A. Molecular evolution of alphaherpes viruses. In: AA AAaG, ed. Varicella-Zoster Virus: Virology and Clinical Management. Cambridge: Cambridge University Press; 2000:25-50.
3. Arvin AM, Moffat JF, Redman R. Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine. Adv Virus Res. 1996;46:263-309. (Pubitemid 3027546)
4. Quinlivan M, Breuer J. Molecular studies of Varicella zoster virus. Rev Med Virol. 2006;16(4):225-250. (Pubitemid 44140720)
5. Davison AJ, Scott JE. The complete DNA sequence of varicellazoster virus. J Gen Virol. 1986;67 (Pt 9):1759-1816. (Pubitemid 16017266)
6. Takayama M, Takayama N, Inoue N, Kameoka Y. Application of long PCR method of identification of variations in nucleotide sequences among varicella-zoster virus isolates. J Clin Microbiol. 1996;34(12):2869-2874. (Pubitemid 26389325)
7. Barrett-Muir W, Hawrami K, Clarke J, Breuer J. Investigation of varicella-zoster virus variation by heteroduplex mobility assay. Arch Virol Suppl. 2001(17):17-25. (Pubitemid 33760014)
8. Sakaoka H, Kurita K, Iida Y, et al. Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries: studies of molecular evolution and molecular epidemiology of the virus. J Gen Virol. 1994;75 (Pt 3):513-527. (Pubitemid 24091808)
9. Umene K, Yoshida M. Genomic characterization of two predominant genotypes of herpes simplex virus type 1. Arch Virol. 1993;131(1- 2):29-46.
10. Poole LJ, Zong JC, Ciufo DM, et al. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J Virol. 1999;73(8):6646-6660. (Pubitemid 29327847)
11. Haberland M, Meyer-Konig U, Hufert FT. Variation within the glycoprotein B gene of human cytomegalovirus is due to homologous recombination. J Gen Virol. 1999;80 ( Pt 6):1495-1500. (Pubitemid 29261481)
12. Ishikawa K, Tsutsui M, Taguchi K, et al. Sequence variation of the gC gene among pseudorabies virus strains. Vet Microbiol. Apr 1996;49(3-4):267-272. (Pubitemid 26167839)
13. Arvin AM, Koropchak CM, Wittek AE. Immunologic evidence of reinfection with varicella-zoster virus. J Infect Dis. 1983;148(2): 200-205. (Pubitemid 13002453)
14. Hall S, Maupin T, Seward J, et al. Second varicella infections: are they more common than previously thought? Pediatrics. 2002;109(6):1068-1073. (Pubitemid 34587432)
15. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1-30; quiz CE32-34.
16. Schmader K, Gnann JW, Jr., Watson CP. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008;197 (Suppl 2):S207-215.
17. Weinberg JM. Herpes zoster: epidemiology, natural history, and common complications. J Am Acad Dermatol. 2007;57(6 Suppl):S130-135.
18. Kleinschmidt-DeMasters BK, Gilden DH. Varicella-Zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med. 2001;125(6):770-780. (Pubitemid 32520521)
19. James WD BT, Elston D. Andrews' Diseases of the Skin: Clinical Dermatology. 10th edition ed: Saunders; 2005.
20. Takahashi M, Otsuka T, Okuno Y, et al. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974;2(7892):1288-1290.
21. Marin M, Guris D, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1-40.
22. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271- 2284.
23. Zostavax [prescribing information] http://www.merck.com/product/ usa/pi-circulars/z/zostavax/zostavax-pi.pdf.
24. Oxman MN, Levin MJ. Vaccination against Herpes Zoster and Postherpetic Neuralgia. J Infect Dis. 2008;197 (Suppl 2):S228-236.
25. Zhang AY, Elmets CA, Camp WL, Elewski BE. New opportunities in preventative dermatology: how far should we go? J Am Acad Dermatol. 2007;56(4):675-676. (Pubitemid 46415627)
26. Levin MJ, Oxman MN, Zhang JH, et al. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis. 2008;197(6):825-835. (Pubitemid 351417005)
27. Reynolds MA, Chaves SS, Harpaz R, et al. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis. 2008;197 (Suppl 2):S224-227.